首頁 > 市場調查報告書 > 生物科技 > 生物材料 > 歐洲的牙科生技材料市場:2011年

聯絡我們?

市場調查報告書

歐洲的牙科生技材料市場:2011年

European Markets for Dental Biomaterials 2011

出版商	Millennium Research Group
出版日期	2011年06月	商品編碼	203774
內容資訊	英文
價格	US $ 5995 Web Access and PDF Download (Single user license) US $ 9000 Web Access and PDF Download (Corporate use license)

簡介
目錄
相關商品

歐洲的牙科生技材料市場:2011年 是由出版商Millennium Research Group在2011年06月所出版的。這份英文市場調查報告書價格從美金5995起跳。

簡介

本報告提供牙科用人工植牙和生物活性物質市場處理概要，各分類市場的各趨勢、材料，各國家概要，2015年為止市場成長預測等相關資料，為您概述為以下內容。

摘要整理

方法論

第1章歐洲的牙科生技材料市場

市場概要
市場分析
- 市場定義
- 牙科骨移植的處置種類
- 不同適應症的牙科骨移植處置
- 不同材料的牙科生技材料處置
- 市場預測
- 推動市場的要素和阻礙要素
競爭分析
- 競爭環境
- 市場佔有率
- 競爭企業
  - Geistlich
  - RTI Biologics
  - Straumann
- 新興企業
  - BioMimetic Therapeutics

第2章代用骨市場

市場概要
市場分析
- 市場定義
  - 自體骨移植
  - 同類移植片
  - 異質骨移植
  - 人造骨移植
  - 並用療法
- 處理
  - 各材料
  - 各國家
- 市場預測
- 推動市場的要素和阻礙要素
競爭分析
- 競爭環境
- 市場佔有率

第3章牙科再生膜市場

市場概要
市場分析
- 市場定義
- 處理
- 市場預測
- 推動市場的要素和阻礙要素
競爭分析
- 競爭環境
- 市場佔有率
第4章組織再生市場
市場概要
市場分析
- 市場定義
- 處理
- 市場預測
- 推動市場的要素和阻礙要素
競爭分析
- 競爭環境
- 市場佔有率

附錄

The European dental biomaterial market comprises bone graft substitutes (BGS), dental membranes, and tissue regeneration products sold in France, Germany, Italy, Spain, Sweden, Switzerland, and the UK. Over the forecast period, market growth will be driven by the aging population - which is the most susceptible to severe periodontal diseases and tooth loss - and an increase in dental implant treatments performed. Additionally, more general practitioners (GPs) are performing dental implant placements due to their lucrative nature, which will boost dental biomaterial usage; these clinicians are not as familiar with the procedures and often employ materials like BGS and dental membranes to ensure the success of their treatments. Growth in average selling prices (ASPs) will be bolstered by an increase in tissue regeneration product prices - fueled by the entrance of a new premium-priced product - and a modest rise in the prices of allografts and xenografts due to increasing harvesting costs. ASP gains will nonetheless be partly offset by cost constraints due to the lingering effects of the economic crisis, the growing use of lower-priced synthetic graft products, and price erosion in the dental membrane segment due to commoditization and price competition. Despite these limitations, dental biomaterial revenues in Europe will grow moderately through 2015.

Companies mentioned in this report:

aap biomaterials
ACE Surgical
Acteon
Artoss
Augma Biomaterials
Bicon Dental Implants
Biocomposites
BioHorizons
Biomatlante
BIOMET 3i
Bioteck
BIOVISION Biomaterial
bredent medical
Ceramisys
Degradable Solutions
Dentaurum
DENTSPLY Friadent
DOT GmbH
ETHICON
Geistlich
Ghimas
Heraeus Kulzer
Implant Direct Sybron International
IMTEC (a 3M Company)
Keystone Dental
LASAK
LH Medical
Mathys
MBP GmbH
NovaBone Products
OraPharma (through distributor Henry Schein)
Osteogenics Biomedical
RESORBA Wundversorgung
RIEMSER Arzneimittel
RTI Biologics (through distributor Zimmer Dental)
Septodont
SIC Invent
Straumann
Synthes
Tecnoss
Tigran Technologies
Tissue Bank of France
TOLMAR
Trinon Titanium
W. L. Gore

RESEARCH METHODOLOGY

This report uses a number of methodologies to gather and present data and analysis. At the outset, a large survey of secondary sources is conducted. These sources act as the basis for the primary research stage, which builds and enhances the quantitative and qualitative attributes of the early research.

Secondary sources include

Government sources:
- Swiss Statistics Website (maintained by the Federal Statistical Office (FSO))
- National Health Service (NHS)
- Statistics Sweden
- Instituto Nacional de Estadistica Spain
- US Census Bureau International Data Base
- International Monetary Fund
Dental biomaterial companies:
- Annual reports, product brochures, corporate profiles, etc.
Internal databases and reports:
- Previous reports on similar/related sources
General Internet searches, medical literature, and newspaper/magazine searches:
- Identifying various centers of specialization and articles that might provide leads for primary research

The secondary research stage builds the foundation for the primary research.

The primary research methodology has four steps:

Step 1: The first step involves an impartial scan of all the information gathered during the secondary research stage to determine its utility based on the specific requirements of this report. Each piece of information is either discarded or marked as high- or low-priority and then organized appropriately as determined by the structure and sectioning of the report.

Step 2: At this stage, early assumptions are formed as to the implications of the information for the various dental biomaterial market segments. These assumptions are then used to determine hypotheses using both inductive and deductive approaches. On the quantitative front, these hypotheses result in full historical and projected market data sets (market sizes - unit sales, average selling prices [ASPs], and revenues - as well as market shares).

Step 3: At this stage, the research is in position for its most important primary phase - expert interviews. Throughout the secondary research phase, industry and medical experts are identified. These experts are then contacted by telephone and asked to participate in interviews on recent trends and developments in the industry. Interviews are either conducted at the time of the initial call or scheduled at the convenience of the expert. Interview questions are tailored to the expertise of each particular interviewee, although in most cases, the most important questions are asked of all experts.

The questions are largely based on the assumptions and hypotheses developed in Step 2, which are then augmented, discarded, or adjusted based on the views and positions put forth. Attempts are made, whenever possible, to cross-check the views of various experts against each other and to reach positions of consensus on issues and market numbers.

Step 4: The final stage of primary research involves individual and group analysis by Millennium Research Group. All research results are assessed and cross-checked thoroughly to determine their validity, relevance, and weight. From this process, qualitative conclusions are reached and data points finalized.

LIST OF FIGURES AND TABLES

EXECUTIVE SUMMARY

METHODOLOGY

1.0 EUROPEAN DENTAL BIOMATERIAL MARKET

1.1. Market Overview
1.2. Market Analysis
- 1.2.1. Market Definitions
  - 1.2.1.1. Indications for Dental Biomaterial Procedures
    - Periodontal Defects
    - Dental Implants
  - 1.2.1.2. Types of Dental Bone Graft Procedures
    - Sinus Lift
    - Ridge Augmentation
    - Ridge Expansion
    - Dental Implant Packing
    - Socket Extraction
- 1.2.2. Dental Bone Graft Procedures by Indication
  - 1.2.2.1. Dental Implant Procedures Utilizing Bone Graft by Type
- 1.2.3. Dental Biomaterial Procedures by Material
- 1.2.4. Market Forecast
- 1.2.5. Market Drivers and Limiters
  - 1.2.5.1. Market Drivers
  - 1.2.5.2. Market Limiters
1.3. Competitive Analysis
- 1.3.1. Competitive Landscape
- 1.3.2. Market Shares
- 1.3.3. Competitor Discussions (in Alphabetical Order)
  - Geistlich
  - RTI Biologics (through distributor Zimmer Dental)
  - Straumann
  - Other
- 1.3.4. Emerging Competitors
  - BioMimetic Therapeutics

2.0 BONE GRAFT SUBSTITUTE MARKET

2.1. Market Overview
2.2. Market Analysis
- 2.2.1. Market Definitions
  - 2.2.1.1. Dental Autografts
  - 2.2.1.2. Dental Allografts
    - Nonproprietary Allografts
    - Proprietary Allografts
  - 2.2.1.3. Dental Xenografts
  - 2.2.1.4. Synthetic Dental Bone Graft Substitutes
  - 2.2.1.5. Combination Therapies
- 2.2.2. Procedures
  - 2.2.2.1. Procedures by Material
  - 2.2.2.2. Procedures by Country
- 2.2.3. Market Forecast
- 2.2.4. Market Drivers and Limiters
  - 2.2.4.1. Market Drivers
  - 2.2.4.2. Market Limiters
2.3. Competitive Analysis
- 2.3.1. Competitive Landscape
- 2.3.2. Market Shares

3.0 DENTAL MEMBRANE MARKET

3.1. Market Overview
3.2. Market Analysis
- 3.2.1. Market Definitions
- 3.2.2. Procedures
  - 3.2.2.1. Procedures by Type
- 3.2.3. Market Forecast
- 3.2.4. Market Drivers and Limiters
  - 3.2.4.1. Market Drivers
  - 3.2.4.2. Market Limiters
3.3. Competitive Analysis
- 3.3.1. Competitive Landscape
- 3.3.2. Market Shares

4.0 TISSUE REGENERATION MARKET

4.1. Market Overview
4.2. Market Analysis
- 4.2.1. Market Definitions
- 4.2.2. Procedures
- 4.2.3. Market Forecast
- 4.2.4. Market Drivers and Limiters
  - 4.2.4.1. Market Drivers
  - 4.2.4.2. Market Limiters
4.3. Competitive Analysis
- 4.3.1. Competitive Landscape

APPENDIX A: MRG ACRONYMS AND INITIALISMS

APPENDIX B: SUPPLEMENTAL FIGURES